Kirkland & Ellis and Willkie Farr & Gallagher advised on CapVest Partners LLP’s agreement to acquire a majority stake in STADA Arzneimittel AG (STADA) from Bain Capital and Cinven.
Kirkland & Ellis advised Bain Capital and Cinven on the sale of a majority stake in STADA Arzneimittel AG (“STADA”) to CapVest Partners LLP. Bain Capital and Cinven will retain a minority stake in STADA.
The Kirkland team included transactional lawyers Benjamin Leyendecker, Philip Goj, Maximilian Liegl, Marcus Commandeur, Tamara Zehentbauer, Sabrina Seitz and Lionel Reich; capital markets lawyers Marwa Elborai and Georg Lorenz; debt finance lawyers Christopher Shield, Sam Sherwood, Jerome Hoyle and Aman Nath; and tax lawyers Michael Ehret and Emanuel Götz.
Willkie advised CapVest Partners LLP on entering into a definitive agreement to acquire the majority stake in STADA from Bain Capital and Cinven. STADA is a leading healthcare and pharmaceuticals company headquartered in Bad Vilbel, Germany, specializing in Consumer Healthcare, Generics and Specialty pharmaceuticals.
The Willkie team is led by Partners David Arnold, Andy Gray, Nils Röver, Dr. Kamyar Abrar and Georg Linde. The team also includes Partners Bettina Bokeloh, Patrick Meiisel, Rita Mitchell, Rahul Saha, Georg Weidenbach, and counsel Jacob Ahme and Alaric Green.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
